PET radiopharmaceuticals: state-of-the-art and future prospects.
about
Fundamentals of positron emission tomography and applications in preclinical drug development.Positron emission tomography (PET) and other nuclear medicine modalities in staging gastrointestinal cancer.Use of positron emission tomography in animal research.Positron emission tomography imaging as a cancer biomarker.Quantitative metrics of net proliferation and invasion link biological aggressiveness assessed by MRI with hypoxia assessed by FMISO-PET in newly diagnosed glioblastomasRadiopharmaceuticals drug interactions: a critical review.
P2860
PET radiopharmaceuticals: state-of-the-art and future prospects.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
PET radiopharmaceuticals: state-of-the-art and future prospects.
@en
type
label
PET radiopharmaceuticals: state-of-the-art and future prospects.
@en
prefLabel
PET radiopharmaceuticals: state-of-the-art and future prospects.
@en
P1476
PET radiopharmaceuticals: state-of-the-art and future prospects.
@en
P2093
P304
P356
10.1016/S0001-2998(98)80028-7
P577
1998-07-01T00:00:00Z